Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAESAR: Reduced Dose Oral Iron in IBD
NCT06321887Phase 3Recruiting
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ferrous fumarate in iron deficiency anemia (IDA), sponsored by Liverpool University Hospitals NHS Foundation Trust. Started Oct 2023; status: recruiting.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06321887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06321887.